Thank You From the Foundation!
The AASLD Foundation offers sincere thanks for the generosity and support of AASLD Committee and SIG leaders. This year, the Foundation hosted our first Committee/SIG Fundraising Challenge. Committees and SIG Steering Committees were given a goal to collectively raise $25,000 to help support a 2022 Pilot Research Award. Our amazing leaders banded together and exceeded this goal raising over $51
The Need for Liver Transplants is Skyrocketing Among Older Americans
Media Contact: Caroline Laurin Phone: (703) 299-9766 Onsite phone: (617)-954-2945 Email: email@example.com ALEXANDRIA, Va. – A new study has found that the proportion of older Americans who need a liver transplant (LT) has sharply increased in recent years, often due to the rising number of cases of nonalcoholic steatohepatitis (NASH). As the U.S. population ages, researchers estimate that more
AASLD Distinguished Achievement Award: Raymond F. Schinazi, PDF, FAASLD
The Distinguished Achievement Award is given to an individual in honor of sustained scientific contributions to the field of liver disease and the scientific foundations of hepatology. The award honors a sustained contribution rather than a single discovery or major achievement. This year’s recipient is Raymond F. Schinazi, PhD, FAASLD, and the Francis Winship Walters Professor of Pediatrics and
HCV Guidance Updates
HCVguidelines.org — a website developed by the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America to provide up-to-date guidance on the management of hepatitis C — was recently revised to reflect important developments in the identification and management of chronic hepatitis C (HCV). Notably, there has been several important updates within the
Hepatology Communications Earns Its First Impact Factor: An Interview with Editor Gyongi Szabo
AASLD’s Open Access journal, Hepatology Communications, rose to new heights this year. The journal, under the leadership of Dr. Gyongyi Szabo, received its first Impact Factor of 5.073 in June, which places it in the top third of all journals in the Gastroenterology/Hepatology category. Through the drive and tenacity of Dr. Szabo’s team, Hepatology Communications was also accepted for inclusion in
AASLD Remembers Two of Its Own
Alan Frederick Hofmann, MD, FAASLD The American Association for the Study of Liver Diseases (AASLD) acknowledges the passing of an esteemed member and fellow who made significant contributions to our field. Alan Frederick Hofmann, MD, FAASLD, passed away on September 7, 2021. Dr. Hofmann was a gastrointestinal physiologist, biochemist, and clinician notable for his extensive basic, translational
Congress Starts the Appropriations Process, But Has a Long Way To Go
As the House and Senate get ready to go on their traditional August recess, we have seen the first signs of movement in the congressional appropriations process. The House Appropriations Committee has released 10 of its 12 FY22 bills, seven of which have been combined into a single bill and passed the House on July 29. Those seven bills include funding for NIH, CDC, HRSA, and the VA. The good news
World Hepatitis Day 2021
On World Hepatitis Day, July 28, 2021, AASLD joins colleagues and community voices around the world with an urgent call to action for Hepatitis Elimination by 2030 because “Hepatitis Can’t Wait.”
AASLD Governance Election Update
AASLD is pleased to announce the election of new Governing Board and Foundation Board members who will begin their terms in January 2022. The 2021 Nominating Committee met on April 6, 2021 and selected finalists for the positions of Councilor, Secretary, Foundation Board Trustee, Councilor-at-Large and members of the 2022 Nominating Committee.
AASLD Remembers Roberto Groszmann, MD, FRCP
The American Association for the Study of Liver Diseases acknowledges the passing of one of its members who made major contributions to our field. Roberto Groszmann, MD, FRCP passed away in New Haven on January 16, 2021.
Alarming New Study Highlights Need For Improved Access To HBV Vaccination, Testing And Treatment
Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that in 2019, more than 500,000 persons died of hepatitis B virus infection, highlighting the urgent need for universal HBV vaccination of children beginning at birth, and scaling up testing and access to care and treatment before people with
More Women Diagnosed With HCV During Pregnancy, but Many Infants Still Not Tested Despite Recommendations From Leading Health Organizations
Media Contact: Caroline Laurin Phone: (703) 299-9766 Email: firstname.lastname@example.org Alexandria, VA – Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases (AASLD)– found that among pregnant women with hepatitis C virus (HCV), more than 25 percent were initially diagnosed during pregnancy screenings, which
Cirrhosis in North American Women on the Rise, Trend Especially Worrisome in Young Women
Media Contact: Caroline Laurin Phone: (703) 299-9766 Email: email@example.com ALEXANDRIA, VA – Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that the burden of cirrhosis in women in North America has increased substantially in recent years, a worrying trend driven by a rise in alcohol
High Abdominal Fat And Low Liver Fat Combo Increases Coronary Heart Disease Risk
Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that the distribution of a person’s body fat affects coronary heart disease risk, with an increased risk of heart events among people with a combination of high visceral adipose tissue (VAT) – abdominal fat─ and low liver fat.